Additions broaden DehydraTECH patent suite for Epilepsy KELOWNA, BC – Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce that… Read More
VANCOUVER, BC – Acuitas Therapeutics, Inc. was named one of BC’s Top Employers of 2025. The Vancouver-based, privately held biotechnology firm is the global leader in the development of delivery… Read More
BURNABY, BC – Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunomodulation platform designed to restore innate immune function, is pleased to report exciting… Read More
TOKYO, JP & TORONTO, ON – PHC Corporation has signed a Master Collaboration Agreement with CCRM to work together on the development of primary T-cell(*1) expansion culture processes that will seek… Read More
VANCOUVER, BC – Eyam Health is excited to announce promising interim results from an ongoing study funded by the Gates Foundation, leading to an extension of grant funding to further… Read More
